Testing acetyl-L-carnitine in early ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a confirmed ALS diagnosis (based on the Gold Coast criteria).
- Your ALS symptoms began less than 24 months ago.
- You can still swallow, feed yourself, and walk (with or without help).
- Your lung function is good, with an FVC test result of 80% or more of normal.
- You have been taking riluzole for at least 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial tests whether a medicine called cyclophosphamide can slow the progression of ALS. It's given to people who have had symptoms for less than 2 years and still have good breathing, to see if calming the immune system can help protect nerve cells.
This study tests whether the drug colchicine can help people with ALS. It aims to see if taking colchicine in addition to your usual riluzole treatment slows the progression of the disease.
This trial tests a medication called acamprosate to see if it can slow down ALS in people who have a specific genetic change (C9orf72). If you have this gene change and ALS, this study might offer a new treatment option.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.